Literature DB >> 33724188

Human cytomegalovirus antagonizes activation of Fcγ receptors by distinct and synergizing modes of IgG manipulation.

Philipp Kolb1,2, Katja Hoffmann1,2, Annika Sievert1,2, Henrike Reinhard3, Eva Merce-Maldonado3, Vu Thuy Khanh Le-Trilling4, Anne Halenius1,2, Dominique Gütle1,2, Hartmut Hengel1,2.   

Abstract

Human cytomegalovirus (HCMV) is endowed with multiple highly sophisticated immune evasion strategies. This includes the evasion from antibody mediated immune control by counteracting host Fc-gamma receptor (FcγR) mediated immune control mechanisms such as antibody-dependent cellular cytotoxicity (ADCC). We have previously shown that HCMV avoids FcγR activation by concomitant expression of the viral Fc-gamma-binding glycoproteins (vFcγRs) gp34 and gp68. We now show that gp34 and gp68 bind IgG simultaneously at topologically different Fcγ sites and achieve efficient antagonization of host FcγR activation by distinct but synergizing mechanisms. While gp34 enhances immune complex internalization, gp68 acts as inhibitor of host FcγR binding to immune complexes. In doing so, gp68 induces Fcγ accessibility to gp34 and simultaneously limits host FcγR recognition. The synergy of gp34 and gp68 is compelled by the interfering influence of excessive non-immune IgG ligands and highlights conformational changes within the IgG globular chains critical for antibody effector function.
© 2021, Kolb et al.

Entities:  

Keywords:  cytomegalovirus; fc receptors; immune evasion; immunoglobulin; immunology; infectious disease; inflammation; microbiology; natural killer cells; virus

Year:  2021        PMID: 33724188     DOI: 10.7554/eLife.63877

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  4 in total

1.  Detection and functional resolution of soluble immune complexes by an FcγR reporter cell panel.

Authors:  Haizhang Chen; Andrea Maul-Pavicic; Martin Holzer; Magdalena Huber; Ulrich Salzer; Nina Chevalier; Reinhard E Voll; Hartmut Hengel; Philipp Kolb
Journal:  EMBO Mol Med       Date:  2021-11-29       Impact factor: 12.137

2.  Antibody escape and global spread of SARS-CoV-2 lineage A.27.

Authors:  Tamara Kaleta; Lisa Kern; Samuel Leandro Hong; Martin Hölzer; Georg Kochs; Julius Beer; Daniel Schnepf; Martin Schwemmle; Nena Bollen; Philipp Kolb; Magdalena Huber; Svenja Ulferts; Sebastian Weigang; Gytis Dudas; Alice Wittig; Lena Jaki; Abdou Padane; Adamou Lagare; Mounerou Salou; Egon Anderson Ozer; Ndodo Nnaemeka; John Kofi Odoom; Robert Rutayisire; Alia Benkahla; Chantal Akoua-Koffi; Abdoul-Salam Ouedraogo; Etienne Simon-Lorière; Vincent Enouf; Stefan Kröger; Sébastien Calvignac-Spencer; Guy Baele; Marcus Panning; Jonas Fuchs
Journal:  Nat Commun       Date:  2022-03-03       Impact factor: 14.919

3.  Circulating multimeric immune complexes contribute to immunopathology in COVID-19.

Authors:  Jakob Ankerhold; Sebastian Giese; Philipp Kolb; Andrea Maul-Pavicic; Reinhard E Voll; Nathalie Göppert; Kevin Ciminski; Clemens Kreutz; Achim Lother; Ulrich Salzer; Wolfgang Bildl; Tim Welsink; Nils G Morgenthaler; Andrea Busse Grawitz; Florian Emmerich; Daniel Steinmann; Daniela Huzly; Martin Schwemmle; Hartmut Hengel; Valeria Falcone
Journal:  Nat Commun       Date:  2022-09-26       Impact factor: 17.694

4.  The secreted protein Cowpox Virus 14 contributes to viral virulence and immune evasion by engaging Fc-gamma-receptors.

Authors:  Ravi F Iyer; David M Edwards; Philipp Kolb; Hans-Peter Raué; Chris A Nelson; Megan L Epperson; Mark K Slifka; Jeffrey C Nolz; Hartmut Hengel; Daved H Fremont; Klaus Früh
Journal:  PLoS Pathog       Date:  2022-09-19       Impact factor: 7.464

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.